News Press release

Professor Matthew Farrer wins 2025 Tom Isaacs Award

Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr Matt Farrer as the winner of the 2025 Tom Isaacs Award, which honours researchers who closely collaborate with the Parkinson’s community. The two organisations were delighted to announce Dr Matt Farrer as winner…


News Research news

Combination therapies: a change in approach for Parkinson’s research

As part of our research strategy, Cure Parkinson’s is seeking to progress research involving combination therapies as a potential method for targeting Parkinson’s progression. Currently, clinical trials of potentially disease-modifying therapies for Parkinson’s are largely focussed on testing single drugs, or monotherapies. These drugs often…


News Research news

Could ambroxol help to slow cognitive change in people with Parkinson’s?   

The results of a phase 2 clinical trial of ambroxol in Canada for people with Parkinson’s dementia were published recently, finding it was safe and tolerable when taken by participants. A proportion of people with Parkinson’s experience cognitive changes – changes to our memory, thinking,…


News Research news

New registry Join Parkinson’s Research aims to boost awareness and accessibility of clinical research studies for Parkinson’s

The Join Parkinson’s Research (JPR) registry is a new online platform where people living with the condition can register to hear about the latest clinical studies. Clinical research studies are vital to improve our understanding of Parkinson’s and help develop new treatments. However, due to…


Improving diversity in Parkinson’s research – The East London Parkinson’s Disease Project

The East London Parkinson’s Disease Project (ELPD) is a study led by Professor Alastair Noyce at Queen Mary University London. This Cure Parkinson’s supported initiative seeks to better understand the experiences of people with Parkinson’s from diverse ethnic backgrounds. Recently, the ELPD team published a…